Edition:
United States

People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

144.10USD
21 Jul 2017
Change (% chg)

$-0.20 (-0.14%)
Prev Close
$144.30
Open
$144.08
Day's High
$145.20
Day's Low
$142.91
Volume
290,782
Avg. Vol
287,617
52-wk High
$147.45
52-wk Low
$95.14

Termeer, Henri 

Mr. Henri A. Termeer was an Independent Director of Abiomed, Inc., Prior to Genzyme Corporation’s acquisition in April 2011 by Sanofi, Mr. Termeer was President, and a director of Genzyme Corporation since 1983, its Chief Executive Officer since 1985 and its Chairman since 1988. Mr. Termeer was a member of the Board of Directors of the Massachusetts Institute of Technology, Massachusetts General Hospital and Partners HealthCare. Mr. Termeer was a member of the Board of Fellows of Harvard Medical School. He was also the Chairman of the Board of Aveo Pharmaceuticals and member of the Board of Directors of Verastem, Inc. Mr. Termeer served as the Deputy Chairman of the Federal Reserve Bank of Boston from 2007 to 2009 and as its Chairman from 2010 through the end of 2011. Mr. Termeer studied economics at the Economische Hogeschool at Erasmus University in The Netherlands and received his Master of Business Administration from the Darden School of Business at the University of Virginia. He passed away on May 12, 2017.

Basic Compensation

Total Annual Compensation, USD 59,274
Restricted Stock Awards, USD 199,768
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 259,042

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Minogue

12,219,300

Michael Tomsicek

2,178,060

David Weber

2,734,970

William Bolt

2,168,680

Andrew Greenfield

536,074

Michael Howley

2,296,710
As Of  30 Mar 2017